Sign in
Taking people in United StatesNo phase

Studying kidney health in young people with type 2 diabetes during puberty

Studies kidney function in children with obesity, prediabetes or type 2 diabetes during puberty.

Key facts

Who runs it
Petter Bjornstad
Where
Aurora and Seattle, United StatesSee the 2 sites
Trial code
Registry title
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Status
Recruiting
People taking part
100 people, planned
Started
27 Sept 2021
Expected to end
1 Dec 2027
Type of study
Observational, 2 groups
Treatments tested
  • Aminohippurate Sodium Inj 20%
  • Iohexol Inj 300 MG/ML
  • Dextran 40
Record updated
24 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teenagers aged 8 to 14 years. Some have high blood sugar and a higher body weight. Others are a control group with normal blood sugar.

Age
8 to 14 years
Sex
All sexes can join.
Disease stage
High-risk group: HbA1c ≥6.0% (42 mmol/mol) without treatment and BMI ≥ 85th percentile. Control group: normal HbA1c ≤5.6% (38 mmol/mol).
Earlier treatment
The high-risk group must not be on treatment for high blood sugar (untreated HbA1c ≥6.0% (42 mmol/mol)).
Biomarker or test result
Type 1 diabetes antibody test must be negative.

Main reasons for not taking part

  • History of chronic kidney disease or acute kidney injury
  • Metabolic disorder that makes fasting unsafe
  • Iodine or penicillin allergy
  • Pregnancy
  • Thrombophilia, MRI contraindications or hormone therapy

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • HbA1c ≥6.0% for untreated high-risk group
  • BMI ≥ 85th %ile for high-risk group
  • Normal HbA1c ≤5.6% for control group
  • Type 1 diabetes (T1D) Antibody negative

Who cannot take part

  • Hormone therapy
  • History of Chronic kidney disease (CKD) or acute kidney injury (AKI)
  • Metabolic disorder prohibiting safe fasting
  • Iodine or penicillin allergy
  • Pregnancy
  • Thrombophilia
  • MRI contraindications

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 14 years old?

Where in United States

  • Children's Hospital ColoradoAurora, United StatesContact: Megan Kelsey, MD, MSTaking people
  • Seattle Children's HospitalSeattle, United StatesContact: Petter M Bjornstad, MDTaking people

About the trial

What the trial wants to find out

Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.

The 2 groups in the trial

  • Youth with overweight/obesity and/or newly diagnosed T2D and elevated HbA1c

    All participants will undergo GFR (Iohexol Inj 300 MG/ML), EPRF (Aminohippurate Sodium Inj 20%), Dextran sieving (Dextran 40 Sodium Inj 0.9%), IVGTT for insulin sensitivity, in addition to BOLD and ASL Kidney MRI

    Treatment: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, and Dextran 40

  • Healthy normal-weight controls

    All participants will undergo GFR (Iohexol Inj 300 MG/ML), EPRF (Aminohippurate Sodium Inj 20%), Dextran sieving (Dextran 40 Sodium Inj 0.9%), IVGTT for insulin sensitivity, in addition to BOLD and ASL Kidney MRI

    Treatment: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, and Dextran 40

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
PANTHER Study: Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress
Plain-language title
Studying kidney health in young people with type 2 diabetes during pubertyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05008276, who can take part
Record updated
24 March 2025